An experimental COVID-19 vaccine produced with technology based on a decades-old method, elicited virus-neutralizing antibodies in higher proportion than the amount induced by mRNA immunizations, a Phase 1 clinical trial ...
Past psychology studies have found that on average, older adults tend to view the world in a more positive light than younger adults. People in their 30s to 50s, in fact, often display a negativity bias, which essentially ...
Research led by the Massachusetts Institute of Technology Sloan School of Management, Cambridge, has found that an intensive food-as-medicine program showed no improvement in glycemic control in patients with type 2 diabetes ...
Scientists have found an experimental small molecule that induces a form of cell death to kill a variety of cancers while enhancing the power of the immune system and leaving healthy cells totally unscathed.
For six years, Professor Christopher Vakoc's lab at Cold Spring Harbor Laboratory has been on a mission to transform sarcoma cells into regularly functioning tissue cells. Sarcomas are cancers that form in connective tissues ...
Aug 28, 2023
0
365
An obscure class of molecules, part of the vast system that helps the human body distinguish "self" from "non-self," may also hold the key to stopping SARS-CoV-2 from commandeering healthy cells, scientists have found in ...
Neuroscience Research Australia and the University of New South Wales, Australia, research has examined the sociodemographic, psychosocial, cognitive and life event predictors of well-being. The study, published in Scientific ...
University of Nevada, Las Vegas, researchers have identified a correlation between Alzheimer's disease and specific gut microbiota populations. In a paper published in Scientific Reports titled "Genetic correlations between ...
Researchers at the Harvard T.H. Chan School of Public Health in Boston, Massachusetts, have good news for anyone sticking to a healthy diet: Good food choices are associated with a lower risk of developing a chronic disease.
A large team of researchers from Denali Therapeutics, working with colleagues from multiple entities in the U.S. and one in Canada, has found that a LRRK2 inhibitor called DNL201 showed no ill effects to volunteers in a clinical ...
